APA (7th ed.) Citation

EE, J., TR, R., JS, C., JM, E., & H, T. (2025). Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle. JCI insight, 11(2), . https://doi.org/10.1172/jci.insight.197759

Chicago Style (17th ed.) Citation

EE, Johnson, Reyes TR, Chamberlain JS, Ervasti JM, and Tasfaout H. "Proteomics-based Evaluation of AAV Dystrophin Gene Therapy Outcomes in Mdx Skeletal Muscle." JCI Insight 11, no. 2 (2025). https://doi.org/10.1172/jci.insight.197759.

MLA (9th ed.) Citation

EE, Johnson, et al. "Proteomics-based Evaluation of AAV Dystrophin Gene Therapy Outcomes in Mdx Skeletal Muscle." JCI Insight, vol. 11, no. 2, 2025, https://doi.org/10.1172/jci.insight.197759.